McNeil

J&J consumer health care division providing 300 reps to detail Alza's pediatric attention hyperactivity deficit disorder Rx drug Concerta following its anticipated late summer launch in the U.S. Approximately 110 McNeil reps will contact pediatricians exclusively, while the rest will detail to general practitioners and family care physicians. Under the agreement with Alza, McNeil will receive payments for its sales efforts and payments based upon specific sales attained. Alza is hoping to leverage McNeil's sales experience in pediatrics with Children's Tylenol and Children's Motrin. The J&J division co-promotes two other Rx drugs: Daiichi's Floxin otic and Allergan's Ocuflox ophthalmic solution